Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial - Perkins, B A; Cherney, D ZI; Partridge, H (Diabetes Care, 2014)
, EK IIb/LoE 2+